Skip to content
  • Maker of $1,000 Hepatitis C pill looks to cut its cost overseas

    NPR - 02/07/2014

    Law professor at Northeastern University in Boston, an adviser to , or Health GAP, notes that Gilead allows generic manufacturers to sell its HIV drugs in over 100 countries.

    “So why not a similarly large number of countries for the hepatitis C drug?” Baker tells Shots. “An important question to ask is what are their access intentions for countries that have high hepatitis C burdens?”

  • Cookies on Northeastern sites

    This website uses cookies and similar technologies to understand your use of our website and give you a better experience. By continuing to use the site or closing this banner without changing your cookie settings, you agree to our use of cookies and other technologies. To find out more about our use of cookies and how to change your settings, please go to our Privacy Statement.